✦ LIBER ✦
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
✍ Scribed by Akamatsu, Hiroaki; Mori, Keita; Naito, Tateaki; Imai, Hisao; Ono, Akira; Shukuya, Takehito; Taira, Tetsuhiko; Kenmotsu, Hirotsugu; Murakami, Haruyasu; Endo, Masahiro; Harada, Hideyuki; Takahashi, Toshiaki; Yamamoto, Nobuyuki
- Book ID
- 121563801
- Publisher
- BioMed Central
- Year
- 2014
- Tongue
- English
- Weight
- 214 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1471-2407
No coin nor oath required. For personal study only.